← Open Payments lookup

TATUM KAROS: Open Payments

NPI 1811537632 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,105 in 61 payments from 12 companies in 2025. Trend: 2023 $1,171 · 2024 $1,156 · 2025 $1,105

Food & beverage: $1,105
CompanyPaymentsAmount
Alkermes, Inc.11$239
Janssen Pharmaceuticals, Inc8$178
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$162
Teva Pharmaceuticals USA, Inc.12$161
Neurocrine BioSciences, Inc.5$130
E.R. Squibb & Sons, L.L.C.4$71
Indivior Inc.3$59
Axsome Therapeutics, Inc.2$32
Luye Pharma (USA) Ltd.1$23
Lundbeck LLC1$18

Products named: ARISTADA, INVEGA SUSTENNA, CAPLYTA, INGREZZA, AUSTEDO XR, COBENFY, SUBLOCADE, UZEDY.

Industry payments across FL — which companies pay providers there.